The use of remifentanil during general anesthesia for caesarean section.
The purpose is to review the neonatal and maternal effects of remifentanil given at induction of general anesthesia for caesarean section and prior to delivery of the baby. Remifentanil seems to have short-lived respiratory depressant effects in approximately 50% of neonates, requiring short periods of mask ventilation or tactile stimulation of the neonate. Remifentanil produces excellent maternal hemodynamic stability avoiding tachycardia and hypertension, possibly reducing the risk of maternal awareness. Remifentanil can be safely used at induction of general anesthesia provided healthcare workers are available to manage short-lived neonatal depression.